Clinical Trial Results

A Phase 1/1b Study of IAM1363 in HER2 Cancers

PHASE1INTERVENTIONAL La Jolla, California +4 more

RECRUITING

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

PHASE3INTERVENTIONAL Mobile, Alabama +4 more

RECRUITING

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

PHASE3INTERVENTIONAL Tucson, Arizona +4 more

RECRUITING

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

PHASE3INTERVENTIONAL Phoenix, Arizona +4 more

RECRUITING

Study of XB010 in Subjects With Solid Tumors

PHASE1INTERVENTIONAL Irvine, California +4 more

RECRUITING

E-Mindfulness Approaches for Living After Breast Cancer

PHASE3INTERVENTIONAL Phoenix, Arizona +4 more

RECRUITING

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

PHASE3INTERVENTIONAL Phoenix, Arizona +4 more

RECRUITING

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

PHASE1INTERVENTIONAL Denver, Colorado +4 more

RECRUITING

Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer

N/AOBSERVATIONAL Oklahoma City, Oklahoma

RECRUITING

Prospective Study to Assess a Diagnostic Aid for Cancer

N/AOBSERVATIONAL Coronado, California +4 more

RECRUITING

Promoting Active Living Among People With Metastatic Breast Cancer

NAINTERVENTIONAL Oklahoma City, Oklahoma

RECRUITING

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

N/AOBSERVATIONAL Fort Smith, Arkansas +4 more

RECRUITING